Open access
Open access
Powered by Google Translator Translator

[Abstract Only] Randomized Trial: Secondary Surgical Cytoreduction Not Beneficial for Recurrent Ovarian Cancer

14 Nov, 2019 | 10:34h | UTC

Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Secondary surgery does not improve overall survival for recurrent ovarian cancer patients – University of Texas M. D. Anderson Cancer Center (free) AND Second surgery for many ovarian cancers found ineffective – Reuters (free)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.